Literature DB >> 31586668

Determinants and Differences in Satisfaction with the Inhaler Among Patients with Asthma or COPD.

Vicente Plaza1, Jordi Giner2, Elena Curto2, M Belén Alonso-Ortiz3, Miren Itxaso Orue4, José María Vega5, Borja G Cosío6.   

Abstract

BACKGROUND: Satisfaction with the inhaler is an important determinant of treatment adherence in patients with asthma and chronic obstructive pulmonary disease (COPD). However, few studies have compared these 2 groups to identify the factors associated with satisfaction with the inhaler.
OBJECTIVE: To assess and compare satisfaction with the inhaler in patients with asthma or COPD and to determine the variables associated with high inhaler satisfaction.
METHODS: A multicenter, cross-sectional study of 816 patients (406 with asthma and 410 with COPD) was conducted. Satisfaction was assessed with the Feeling of Satisfaction with Inhaler (FSI-10) questionnaire. All participants completed the Test of Adherence to Inhalers and either the Asthma Control Test (ACT) or the COPD Assessment Test (CAT).
RESULTS: Overall, the asthma group was significantly more satisfied with the inhaler (mean [standard deviation] FSI-10 scores: 44.1 [6.5] vs 42.0 [7.7]; P < .001) and more satisfied on most (7 of 10; 70%) items. Patients with asthma were significantly more satisfied with the inhaler regardless of the adherence level or the type of nonadherence pattern. Younger age, good disease control (ACT ≥20 or CAT ≤10), previous inhaler training, and absence of unwitting nonadherence were all independently and significantly associated with high inhaler satisfaction.
CONCLUSIONS: Age, disease control, and training in inhalation technique all play a more significant role than the specific diagnosis in explaining satisfaction with the device in patients with asthma and COPD. These findings underscore the need to provide better training and more active monitoring of the inhalation technique to improve patient satisfaction, treatment adherence, and clinical outcomes.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asthma; Chronic obstructive; Nebulizers; Patient compliance; Patient satisfaction; Pulmonary disease; Self-reported success; Vaporizers

Mesh:

Substances:

Year:  2019        PMID: 31586668     DOI: 10.1016/j.jaip.2019.09.020

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  5 in total

1.  The Relationship Between the "Adherence Starts with Knowledge-20" Questionnaire and Clinical Factors in Patients with COPD: A Multi-Center, Cross-Sectional Study.

Authors:  Kaho Akimoto; Kuniaki Hirai; Tomohiro Matsunaga; Keisuke Kaneko; Hatsuko Mikuni; Tomoko Kawahara; Tomoki Uno; Akiko Fujiwara; Yoshito Miyata; Shin Ohta; Tetsuya Homma; Hideki Inoue; Fumihiro Yamaguchi; Sojiro Kusumoto; Shintaro Suzuki; Akihiko Tanaka; Hironori Sagara
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-12-04

2.  The effects of repeated inhaler device handling education in COPD patients: a prospective cohort study.

Authors:  June Hong Ahn; Jin Hong Chung; Kyeong-Cheol Shin; Hyun Jung Jin; Jong Geol Jang; Mi Suk Lee; Kwan Ho Lee
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

Review 3.  How to Choose the Right Inhaler Using a Patient-Centric Approach?

Authors:  Didier Cataldo; Shane Hanon; Rudi V Peché; Daniel J Schuermans; Jean M Degryse; Isabelle A De Wulf; Karin Elinck; Mathias H Leys; Peter L Rummens; Eric Derom
Journal:  Adv Ther       Date:  2022-01-26       Impact factor: 3.845

4.  Serum prednisolone levels as a marker of oral corticosteroid adherence in severe asthma.

Authors:  J Michael Ramsahai; Emily King; Robert Niven; Gael Tavernier; Peter A B Wark; Jodie L Simpson
Journal:  BMC Pulm Med       Date:  2020-08-27       Impact factor: 3.317

5.  Preference for Easyhaler® Over Previous Dry Powder Inhalers in Asthma Patients: Results of the DPI PREFER Observational Study.

Authors:  Francisco Javier Alvarez-Gutiérrez; Ana Gómez-Bastero Fernández; Juan Francisco Medina Gallardo; Carlos Campo Sien; Paula Rytilä; Julio Delgado Romero
Journal:  Patient Prefer Adherence       Date:  2021-02-16       Impact factor: 2.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.